DRAP ENLISTED MEDICAL DEVICE
HTI (HTI BIOCHEM FC-360 CHEMISTRY ANALYZER) [FC360-10000] is enlisted with DRAP under number MDIE-0000408 as a Class A (low risk) medical device, imported. The listed holder is IBS Pharmaceuticals. It is listed as valid until 27 May 2027.
Screening result
MDIE-0000408 · the class is taken from DRAP's list for this number
DRAP enlisted Class A list, 28 Aug 2025
ELI-00604
| Device | HTI (HTI BIOCHEM FC-360 CHEMISTRY ANALYZER) [FC360-10000] |
|---|---|
| Class | A |
| Listed holder | IBS Pharmaceuticals |
| Holder address | Office No.634, 6thFloor, Pak Medical Center, Khyber Bazar, Peshawar |
| Manufacturing site | M/s High Technology, Inc (HTI) 20 Alice Agnew Dr., North Attleboro, MA 02763 USA |
| Issued | 28 May 2022 |
| Renewal date | 27 May 2027 |
| Licence | ELI-00604 |
Specifications
No supplier specifications yet.
Supplier of this device? Add specifications (free during launch)
Sign in or create a free account to add specifications.
Screened 6 Oct 2026, 15:53 (Pakistan time). A screening aid, not an official DRAP verification.
More devices from this holder
Other DRAP registrations and enlistments listed for the same company.
| MDIE-0000407 | Automated hematology HTI-MCC-20 Plus analyzer | Class A |
| MDIR-0002698 | Bionen Needle Electrodes for EMG Needle (Needle Electrodes for EMG) | Class B |
Corrections
Is something on this page wrong? Report a correction
Corrections are checked against the evidence before anything changes on this page.
Screen another number
Source: DRAP's published provisional lists. A screening aid, not an official DRAP verification; confirm with DRAP and the supplier's original documents.
